OR WAIT null SECS
San Diego, CA – DIA’s 45th Annual Meeting – June 22, 2009 – Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced immediate availability of the InForm™ Global Trial Management (GTM) eClinical solution. The maturation of the electronic data capture (EDC) clinical trial market has brought with it a paradigm shift in usability requirements whereby longer and more complex trials are managed by more sophisticated and knowledgeable EDC users who require more information. The result of over two years of comprehensive customer research and testing, the InForm GTM product represents an evolution to address this paradigm shift with a redesigned user interface that simplifies navigation to help users reach conclusions quickly, reduce errors, quickly discern the most important pieces of information and streamline workflow.
For reasons including access to new patient populations, cost-effectiveness and opening up new drug markets, clinical trials are increasingly conducted on a global basis. InForm GTM responds to this trend as well, providing a single environment that enables study sponsors to streamline the management of clinical trial data from design through submission, all within a single environment for use in regional or global trials. The ability to efficiently code multi-trial adverse event terms, written in a variety of languages and syllabaries, to common industry-standard terms within one central environment helps maximize operational efficiencies.
“Widespread adoption of InForm in real-world implementations has given us the benefit of extensive experience in helping customers maximize EDC solutions for clinical trials on a global basis,” said Bob Weiler, chairman and CEO, Phase Forward. “The InForm GTM solution is a major new release that capitalizes on this experience. Responding to changes in user demands for EDC solutions today, InForm GTM provides a completely redesigned interface that sets a new standard for eClinical solutions, and an integrated, unified environment for use in regional and multi-language global trials.”
The InForm GTM solution also evidences Phase Forward’s strategy to offer customers of all sizes and in all regions of the world an integrated clinical research system (ICRS) from study set-up, through analysis and submission. The InForm GTM solution, together with Phase Forward’s Clarix™ interactive response technology (IRT) for randomization and trial supply management; the recently acquired Waban Software platform for the management of all clinical data, analysis and reports; and the Empirica™ safety and pharmacovigilance product sets, offers customers an end-to-end eClinical solution for efficiently managing all their trials.
Phase Forward will be showcasing InForm GTM at DIA’s 45th Annual Meeting in San Diego at booth #729.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 290 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.